5 Results for "

benzimidazothiazole

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "benzimidazothiazole" in MCE Product Catalog:

14
14 Cited Publications
Cat. No.: HY-108896
CAS No.: 138614-30-9
Purity:  99.85%
Synonyms: HOE 140 acetate
Target:  

Bradykinin Receptor

Research Areas:  

Inflammation/Immunology

Icatibant acetate (HOE-140 acetate) is a potent and specific peptide antagonist of bradykinin B2 receptor with an IC50 and Ki of 1.07 nM and 0.798 nM respectively .
loading...
    loading...
Cat. No.: HY-115921
CAS No.: 2910876-54-7
Target:  

COX

Research Areas:  

Inflammation/Immunology

Anti-inflammatory agent 9 (compound 28) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 9 expresses activity on COX-2 enzyme more than COX-1. Anti-inflammatory agent 9 is orally active .
loading...
    loading...
Cat. No.: HY-115922
CAS No.: 2910876-55-8
Target:  

COX

Research Areas:  

Inflammation/Immunology

Anti-inflammatory agent 10 (compound 30) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 10 expresses activity on COX-2 enzyme more than COX-1. Anti-inflammatory agent 10 is orally active .
loading...
    loading...
Cat. No.: HY-106050
CAS No.: 58433-11-7
Synonyms: Wy 18251
Target:  

COX

Research Areas:  

Inflammation/Immunology Cancer

Tilomisole (Wy 18251) is a benzimidazothiazole experimental agent with anti-inflammatory activity. Tilomisole causes less agranulocytosis than levamisole, but retains immunomodulating capabilities. Tilomisole is orally active. Tilomisole has the potential for the research of cancer and inflammation .
loading...
    loading...
Cat. No.: HY-115920
CAS No.: 1103920-19-9
Target:  

COX

Research Areas:  

Inflammation/Immunology

Anti-inflammatory agent 8 (compound 13) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 8 expresses activity on COX-2 enzyme more than COX-1 with an IC50 of 0.09 nM. Anti-inflammatory agent 8 is orally active .
loading...
    loading...